We are live on ! Find out more
KROS icon

Keros Therapeutics
KROS

99 hedge funds and large institutions have $944M invested in Keros Therapeutics in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

131,300% more call options, than puts

Call options by funds: $6.57M | Put options by funds: $5K

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

73% more capital invested

Capital invested by funds: $545M → $944M (+$399M)

25% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 24

13% more funds holding

Funds holding: 88 → 99 (+11)

9.93% more ownership

Funds ownership: 59.12% → 69.05% (+9.9%)

Holders
99
Holders Change
+11
Holders Change %
+12.5%
% of All Funds
1.52%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
26
Increased
30
Reduced
24
Closed
15
Calls
$6.57M
Puts
$5K
Net Calls
+$6.57M
Net Calls Change
+$6.57M

Top Buyers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
+$18.9M
2
OCA
Octagon Capital Advisors
New York
+$17M
3
Alkeon Capital Management
Alkeon Capital Management
New York
+$11.2M
4
CAM
Cormorant Asset Management
Massachusetts
+$7.48M
5
FFM
Fairmount Funds Management
Pennsylvania
+$7.16M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$6.44M
2
APM
Avidity Partners Management
Texas
-$5.74M
3
WP
Woodline Partners
California
-$5.57M
4
OM
Opaleye Management
Massachusetts
-$4.33M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$5.75M -$10.4K -208 -0.2%
KHLMVGHM
27
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
$5.6M – – –
WP
28
Woodline Partners
California
$4.46M -$5.57M -111,623 -59%
PHP
29
Parkman Healthcare Partners
Connecticut
$4.09M +$3.48M +69,861 New
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$3.69M -$4.27M -85,572 -58%
Millennium Management
31
Millennium Management
New York
$3.09M -$6.44M -129,132 -71%
N
32
Nuveen
North Carolina
$2.97M -$231K -4,625 -7%
Allianz Asset Management
33
Allianz Asset Management
Germany
$2.79M +$2.39M +47,847 New
KCM
34
Kennedy Capital Management
Missouri
$2.73M +$146K +2,918 +7%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.71M +$167K +3,345 +8%
AS
36
Altshuler Shaham
Israel
$2.64M – – –
Rafferty Asset Management
37
Rafferty Asset Management
New York
$2.15M +$621K +12,459 +51%
IHAM
38
Integral Health Asset Management
New York
$2.05M +$1.75M +35,000 New
JP Morgan Chase
39
JP Morgan Chase
New York
$1.94M +$1.13M +22,697 +216%
Citigroup
40
Citigroup
New York
$1.88M +$674K +13,518 +73%
Bank of America
41
Bank of America
North Carolina
$1.83M +$60.6K +1,216 +4%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.64M – – –
AA
43
ALPS Advisors
Colorado
$1.58M -$76.2K -1,528 -5%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.13M +$21K +422 +2%
Wellington Management Group
45
Wellington Management Group
Massachusetts
$1.1M +$935K +18,757 New
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$1.05M – – –
CA
47
CHI Advisors
New York
$1.02M +$244K +4,891 +39%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.01M +$218K +4,380 +34%
SSA
49
Schonfeld Strategic Advisors
New York
$939K +$800K +16,044 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$813K -$14.1K -283 -2%
1
2
3 4 5

KROS Hedge Fund Activity: Q4 2021 in Review

99 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Keros Therapeutics (KROS) for Q4 2021, worth a combined $944M — up 73% from $545M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new KROS positions and 15 closed out — a net gain of 11 holders — while 30 added to existing stakes and 24 trimmed.

The largest buyer was First Light Asset Management, adding an estimated $18.9M. The largest seller was Millennium Management, cutting an estimated $6.44M.

  • 99 institutional investors held Keros Therapeutics (KROS) as of Q4 2021, up from 88 in Q3 2021.
  • Funds reported $944M of Keros Therapeutics stock for Q4 2021, up 73% quarter-over-quarter.
  • 26 funds opened new Keros Therapeutics positions in Q4 2021 and 15 closed out, a net change of +11 holders.
  • The largest Keros Therapeutics buyer in Q4 2021 was First Light Asset Management, an estimated $18.9M added.
  • The largest Keros Therapeutics seller in Q4 2021 was Millennium Management, an estimated $6.44M sold.

Based on aggregated 13F filings for Q4 2021.